MedPath

Comparing Vortioxetine, Escitalopram and fluoxetine on adults with mild and moderate depressio

Phase 4
Conditions
Health Condition 1: F30-F39- Mood [affective] disorders
Registration Number
CTRI/2023/04/051622
Lead Sponsor
Janani D
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Meet the ICD-11 diagnostic criteria for depression,

Age between 18 to 65 years, MADRS score of 7-19 Mild & 20-34 moderate depression and Signs informed consent

Exclusion Criteria

Using MINI to screen out people with other Psychiatric illness eg. substance use, mania, eating disorder, MADRS score >34: Severe depression,

Pregnant mother and not giving consent

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Montgomery and Asberg Depression Rating scale, 50% improvementTimepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
Side-effects experiencedTimepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath